SEC Form 4 · accession 0001104659-26-071506
Cryoport, Inc. · CYRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramkumar Mandalam
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 9:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001124524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | A | 10,350 | $0.00 | A | 91,108 | D | |
| Common StockF2 | Jun 8, 2026 | S | 23,214 | $15.4412 | D | 67,894 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy Common Stock)F3 | $15.70 | Jun 5, 2026 | A | 16,077 | A | — | Jun 5, 2033 | Common Stock | 16,077 | 16,077 | D |
Explanation of responses
- F1Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F31/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.